Abstract
In this edition of the BJOG, Weller and colleagues present a population based study in a single centre over 12 years in which 1,872 of 114,961 women took clomiphene, and showed no increase in the rate of overall or specific major malformations. It provides the best available evidence to date that clomiphene (clomifene) citrate is safe. This article is protected by copyright. All rights reserved.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: BJOG : an international journal of obstetrics and gynaecology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
